Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome

Summary

This is a prospective randomized double blinded study comparing the effect on duration of pharmacologic treatment and duration of hospital stay when using clonidine at 12 µg/kilogram/day as an adjunct to oral morphine as compared to morphine monotherapy in the management of term and near term infants with neonatal abstinence syndrome (NAS)

Timeline

Start

2018-04-30

Primary completion

2018-12-12

Completion

2018-12-12

Drugs

Indications